According to BCC Research, Single-Use Technology for Biopharmaceuticals will Reach $3 Billion Globally in 2020

Share Article

According to the new report from BCC Research, the global revenue for single use technology reached $1.4 billion and $1.7 billion in 2013 and 2014, respectively. This market is expected to grow at a compound annual growth rate (CAGR) of 11.7% to nearly $3.0 billion for the period 2014-2019.

The global revenue for single use technology is expected to reach $3.0 billion in 2019

Wellesley, Mass., June 12, 2015 – Single-use systems address specialized needs by reducing capital costs of drugs and their time-to-market. Research and development spending, increasing competition and new technologies are all serving to give the market new impetus according to BCC Research’s latest report on single-use technologies for the biopharmaceutical market. The global market reached $1.4 billion and $1.7 billion in 2013 and 2014, respectively. This market is anticipated to grow at a compound annual growth rate (CAGR) of 11.7% to nearly $3 billion for the period 2014-2019.

Single-use technologies can be applied to upstream as well as downstream bioprocessing, from formulation to filling. These technologies are used in the production of all types of biopharmaceuticals. Changes in lifestyles and healthcare systems, and increasing demand for drugs at reduced prices, has led to the development of facilities that can produce more than one product, offering flexibility and scalability.

“Single-use/disposable technology has emerged over the past decade as a cost-effective and flexible basis for biopharmaceutical manufacturing. The biopharmaceutical industry is rapidly adopting single-use technology for clinical trials, product launches and commercial production of biomolecules to provide cost-effective and flexible process capabilities,” says BCC Research analyst Shalini S. Dewan. “These technologies have requirements, advantages and disadvantages that differ from traditional reusable technology.”

Single-Use Technologies for Biopharmaceuticals: Global Markets (BIO099B) offers a view on the necessity of implementing single-use techniques from the perspective of quality product development. This study looks at the growth of single-use technology equipment manufacturers and users. Pharmaceutical, biotechnical companies and research institutes will find this study to be of interest.

Editors and reporters who wish to speak with the analyst should contact Steven Cumming at

About BCC Research
BCC Research publishes market research reports that make organizations worldwide more profitable with intelligence that drives smart business decisions. These reports cover today's major industrial and technology sectors, including emerging markets. For more than 40 years we've helped customers identify new market opportunities with accurate and reliable data and insight, including market sizing, forecasting, industry overviews, and identification of significant trends and key market participants. We partner with analysts who are experts in specific areas of industry and technology, providing unbiased measurements and assessments of global markets. Recently selected as the world’s greatest market research company, BCC Research is a unit of Eli Global, LLC. Visit our website at Contact us: (+1) 781-489-7301 (U.S. Eastern time), or email

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Steven Cumming
BCC Research
+1 (781) 489-7301 Ext: 632
Email >
Follow >
Visit website